Increased Glyceraldehyde-3-Phosphate Dehydrogenase Gene Expression in Human Cervical Cancers

This publication has 19 references indexed in Scilit:

• CUMC-6, a New Diploid Human Cell Line Derived from a Squamous Carcinoma of the Uterine Cervix
  Gynecologic Oncology, 1996
• Emerging new functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells
  Life Sciences, 1996
• A mutation in glyceraldehyde 3-phosphate dehydrogenase alters endocytosis in CHO cells.
  The Journal of cell biology, 1995
• Uracil DNA-glycosylase/glyceraldehyde-3-phosphate dehydrogenase is an Ap4A binding protein
  Biochemistry, 1995
• The mode of actions of glyceraldehyde‐3‐phosphate dehydrogenase identified as an immunoglobulin production stimulating factor
  FEBS Letters, 1995
• Establishment and Characterization of a Cell Line (CUMC-3) Derived from a Human Squamous Carcinoma of the Uterine Cervix
  Gynecologic Oncology, 1995
• Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes
  Carcinogenesis: Integrative Cancer Research, 1994
• Analysis of the structure and expression of the c-myc oncogene in cervical tumor and in cervical tumor-derived cell lines
  Biochemical and Biophysical Research Communications, 1989
• Increased expression of glycolysis‐associated genes in oncogene‐transformed and growth‐accelerated states
  Molecular Carcinogenesis, 1989
• On the Origin of Cancer Cells
  Science, 1956